Literature DB >> 34159630

Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.

Jeff Lane1, Audrey Brezak1, Pragna Patel2, Andre R Verani2, Irene Benech2, Aaron Katz1.   

Abstract

Adolescent girls and young women (aged 15-24 years; AGYW) continue to carry a disproportionate burden of HIV in sub-Saharan Africa. Pre-exposure prophylaxis (PrEP) helps reduce the risk of acquiring HIV for persons at substantial risk, including AGYW. As countries plan for the rollout of PrEP across sub-Saharan Africa, PrEP policies and programs could address the unique needs of AGYW. The purpose of this analysis was to identify policy considerations to improve AGYW access to PrEP. After reviewing the literature, we identified 13 policy considerations that policymakers and stakeholders could evaluate when developing or reviewing PrEP-related policies. We sorted these considerations into five categories, which together comprise an AGYW Access to PrEP Framework: AGYW-friendly delivery systems, clinical eligibility and adherence support, legal barriers and facilitators, affordability, and community and AGYW outreach. We also reviewed policies in three countries (Kenya, South Africa, and Uganda) to explore how PrEP-related policies addressed these considerations. Some of these policies addressed some of the 13 policy considerations, but none of the policies directly addressed the unique needs of AGYW for accessing PrEP. To improve access to PrEP for AGYW, country policies could include specific components that address these 13 considerations. To reach AGYW effectively, each country could use the 13 considerations we have identified to analyze current policies to identify existing programmatic barriers to AGYW accessing HIV services and address these barriers in PrEP-related policies.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV and AIDS; PrEP; adolescent girls and young women; adolescent health; health policy; pre-exposure prophylaxis; prevention

Mesh:

Substances:

Year:  2021        PMID: 34159630      PMCID: PMC8908770          DOI: 10.1002/hpm.3252

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  72 in total

1.  Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.

Authors:  Albert Y Liu; Nancy A Hessol; Eric Vittinghoff; K Rivet Amico; Elizabeth Kroboth; Jonathan Fuchs; Risha Irvin; R Craig Sineath; Travis Sanchez; Patrick S Sullivan; Susan P Buchbinder
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

Review 2.  Resourcing resilience: social protection for HIV prevention amongst children and adolescents in Eastern and Southern Africa.

Authors:  Elona Toska; Lesley Gittings; Rebecca Hodes; Lucie D Cluver; Kaymarlin Govender; K Emma Chademana; Vincent Evans Gutiérrez
Journal:  Afr J AIDS Res       Date:  2016-07       Impact factor: 1.300

3.  Self-Consent for HIV Prevention Research Involving Sexual and Gender Minority Youth: Reducing Barriers Through Evidence-Based Ethics.

Authors:  Celia B Fisher; Miriam R Arbeit; Melissa S Dumont; Kathryn Macapagal; Brian Mustanski
Journal:  J Empir Res Hum Res Ethics       Date:  2016-03-07       Impact factor: 1.742

Review 4.  The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.

Authors:  Nelly R Mugo; Kenneth Ngure; Michael Kiragu; Elizabeth Irungu; Nduku Kilonzo
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

5.  From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.

Authors:  Sarit A Golub; Kristi E Gamarel; H Jonathon Rendina; Anthony Surace; Corina L Lelutiu-Weinberger
Journal:  AIDS Patient Care STDS       Date:  2013-04       Impact factor: 5.078

6.  Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.

Authors:  Andreas B Eisingerich; Ana Wheelock; Gabriela B Gomez; Geoffrey P Garnett; Mark R Dybul; Peter K Piot
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

7.  Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.

Authors:  Timothy B Hallett; Jared M Baeten; Renee Heffron; Ruanne Barnabas; Guy de Bruyn; Íde Cremin; Sinead Delany; Geoffrey P Garnett; Glenda Gray; Leigh Johnson; James McIntyre; Helen Rees; Connie Celum
Journal:  PLoS Med       Date:  2011-11-15       Impact factor: 11.069

8.  Status of HIV Epidemic Control Among Adolescent Girls and Young Women Aged 15-24 Years - Seven African Countries, 2015-2017.

Authors:  Kristin Brown; Daniel B Williams; Steve Kinchen; Suzue Saito; Elizabeth Radin; Hetal Patel; Andrea Low; Stephen Delgado; Owen Mugurungi; Godfrey Musuka; Beth A Tippett Barr; E Amaka Nwankwo-Igomu; Leala Ruangtragool; Avi J Hakim; Thokozani Kalua; Rose Nyirenda; Gertrude Chipungu; Andrew Auld; Evelyn Kim; Danielle Payne; Nellie Wadonda-Kabondo; Christine West; Elizabeth Brennan; Beth Deutsch; Anteneh Worku; Sasi Jonnalagadda; Lloyd B Mulenga; Kumbutso Dzekedzeke; Danielle T Barradas; Haotian Cai; Sundeep Gupta; Stanley Kamocha; Margaret A Riggs; Karampreet Sachathep; Wilford Kirungi; Joshua Musinguzi; Alex Opio; Sam Biraro; Elizabeth Bancroft; Jennifer Galbraith; Herbert Kiyingi; Mansoor Farahani; Wolfgang Hladik; Edith Nyangoma; Choice Ginindza; Zandile Masangane; Fortune Mhlanga; Zandile Mnisi; Pasipamire Munyaradzi; Amos Zwane; Sean Burke; Felix B Kayigamba; Harriet Nuwagaba-Biribonwoha; Ruben Sahabo; Trong T Ao; Chiara Draghi; Caroline Ryan; Neena M Philip; Fausta Mosha; Aroldia Mulokozi; Phausta Ntigiti; Angela A Ramadhani; Geoffrey R Somi; Cecilia Makafu; Veronicah Mugisha; Julius Zelothe; Kayla Lavilla; David W Lowrance; Rennatus Mdodo; Elizabeth Gummerson; Paul Stupp; Kyaw Thin; Koen Frederix; Stefania Davia; Amee M Schwitters; Stephen D McCracken; Yen T Duong; David Hoos; Bharat Parekh; Jessica E Justman; Andrew C Voetsch
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-12       Impact factor: 17.586

Review 9.  Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.

Authors:  Florence M Koechlin; Virginia A Fonner; Sarah L Dalglish; Kevin R O'Reilly; Rachel Baggaley; Robert M Grant; Michelle Rodolph; Ioannis Hodges-Mameletzis; Caitlin E Kennedy
Journal:  AIDS Behav       Date:  2017-05

10.  Vital need to engage the community in HIV control in South Africa.

Authors:  Stefan Hanson; Yanga Zembe; Anna Mia Ekström
Journal:  Glob Health Action       Date:  2015-08-07       Impact factor: 2.640

View more
  2 in total

1.  "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.

Authors:  Zoe Duby; Brittany Bunce; Chantal Fowler; Kim Jonas; Kate Bergh; Darshini Govindasamy; Colleen Wagner; Catherine Mathews
Journal:  AIDS Behav       Date:  2022-07-06

2.  Oral PrEP Consultations Among Adolescent Girls and Young Women in Kisumu County, Kenya: Insights from the DREAMS Program.

Authors:  Craig J Heck; Sanyukta Mathur; Habel Alwang'a; Oluoch-Madiang' Daniel; Rael Obanda; Mophine Owiti; Jerry Okal
Journal:  AIDS Behav       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.